nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLC15A1—Lisinopril—systemic scleroderma	0.0955	0.126	CbGbCtD
Glyburide—SLC15A1—Captopril—systemic scleroderma	0.0715	0.0941	CbGbCtD
Glyburide—ABCG2—Leflunomide—systemic scleroderma	0.062	0.0817	CbGbCtD
Glyburide—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0424	0.0558	CbGbCtD
Glyburide—SLCO1A2—Prednisone—systemic scleroderma	0.0409	0.0538	CbGbCtD
Glyburide—SLC22A6—Captopril—systemic scleroderma	0.0394	0.0519	CbGbCtD
Glyburide—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0383	0.0505	CbGbCtD
Glyburide—ABCC3—Methotrexate—systemic scleroderma	0.0374	0.0493	CbGbCtD
Glyburide—ALB—Captopril—systemic scleroderma	0.0336	0.0442	CbGbCtD
Glyburide—SLC22A7—Methotrexate—systemic scleroderma	0.0293	0.0385	CbGbCtD
Glyburide—ALB—Mycophenolate mofetil—systemic scleroderma	0.0264	0.0348	CbGbCtD
Glyburide—ABCB1—Lisinopril—systemic scleroderma	0.0234	0.0309	CbGbCtD
Glyburide—CYP2C9—Leflunomide—systemic scleroderma	0.023	0.0303	CbGbCtD
Glyburide—ABCC1—Methotrexate—systemic scleroderma	0.023	0.0302	CbGbCtD
Glyburide—ALB—Prednisone—systemic scleroderma	0.0211	0.0278	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—systemic scleroderma	0.0205	0.027	CbGbCtD
Glyburide—ABCB1—Captopril—systemic scleroderma	0.0176	0.0231	CbGbCtD
Glyburide—ABCC2—Methotrexate—systemic scleroderma	0.017	0.0224	CbGbCtD
Glyburide—ABCG2—Methotrexate—systemic scleroderma	0.0154	0.0202	CbGbCtD
Glyburide—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0138	0.0182	CbGbCtD
Glyburide—CYP2C19—Prednisone—systemic scleroderma	0.0137	0.018	CbGbCtD
Glyburide—SLC22A6—Methotrexate—systemic scleroderma	0.0124	0.0164	CbGbCtD
Glyburide—ABCB1—Prednisone—systemic scleroderma	0.011	0.0145	CbGbCtD
Glyburide—ALB—Methotrexate—systemic scleroderma	0.0106	0.014	CbGbCtD
Glyburide—CYP2C9—cardial valve—systemic scleroderma	0.0097	0.162	CbGeAlD
Glyburide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00828	0.0109	CbGbCtD
Glyburide—CYP3A4—Prednisone—systemic scleroderma	0.00662	0.00872	CbGbCtD
Glyburide—ABCA1—artery—systemic scleroderma	0.00554	0.0928	CbGeAlD
Glyburide—ABCB1—Methotrexate—systemic scleroderma	0.00554	0.0073	CbGbCtD
Glyburide—ABCA1—blood vessel—systemic scleroderma	0.00432	0.0723	CbGeAlD
Glyburide—ABCC9—smooth muscle tissue—systemic scleroderma	0.00299	0.05	CbGeAlD
Glyburide—KCNJ5—lung—systemic scleroderma	0.0026	0.0435	CbGeAlD
Glyburide—CPT1A—connective tissue—systemic scleroderma	0.00238	0.0398	CbGeAlD
Glyburide—ABCA1—connective tissue—systemic scleroderma	0.00221	0.0371	CbGeAlD
Glyburide—ABCA1—skin of body—systemic scleroderma	0.002	0.0335	CbGeAlD
Glyburide—ABCC9—lung—systemic scleroderma	0.00197	0.033	CbGeAlD
Glyburide—CPT1A—digestive system—systemic scleroderma	0.00172	0.0287	CbGeAlD
Glyburide—CPT1A—tendon—systemic scleroderma	0.00163	0.0273	CbGeAlD
Glyburide—ABCA1—digestive system—systemic scleroderma	0.0016	0.0268	CbGeAlD
Glyburide—CFTR—digestive system—systemic scleroderma	0.00151	0.0253	CbGeAlD
Glyburide—CPT1A—lung—systemic scleroderma	0.00143	0.024	CbGeAlD
Glyburide—ABCA1—lung—systemic scleroderma	0.00134	0.0224	CbGeAlD
Glyburide—CFTR—lung—systemic scleroderma	0.00126	0.0211	CbGeAlD
Glyburide—ABCB11—digestive system—systemic scleroderma	0.00124	0.0207	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—systemic scleroderma	0.00119	0.0199	CbGeAlD
Glyburide—SLC22A7—digestive system—systemic scleroderma	0.00112	0.0187	CbGeAlD
Glyburide—KCNJ11—tendon—systemic scleroderma	0.00097	0.0162	CbGeAlD
Glyburide—SLC15A1—digestive system—systemic scleroderma	0.000898	0.015	CbGeAlD
Glyburide—ABCC3—digestive system—systemic scleroderma	0.000789	0.0132	CbGeAlD
Glyburide—SLCO2B1—digestive system—systemic scleroderma	0.000735	0.0123	CbGeAlD
Glyburide—SLCO2B1—tendon—systemic scleroderma	0.0007	0.0117	CbGeAlD
Glyburide—SLCO1A2—digestive system—systemic scleroderma	0.000676	0.0113	CbGeAlD
Glyburide—ABCC3—lung—systemic scleroderma	0.000659	0.011	CbGeAlD
Glyburide—ABCC2—digestive system—systemic scleroderma	0.00063	0.0105	CbGeAlD
Glyburide—SLCO2B1—lung—systemic scleroderma	0.000614	0.0103	CbGeAlD
Glyburide—ABCB1—blood vessel—systemic scleroderma	0.000612	0.0102	CbGeAlD
Glyburide—ABCC2—tendon—systemic scleroderma	0.0006	0.01	CbGeAlD
Glyburide—SLCO1A2—lung—systemic scleroderma	0.000565	0.00946	CbGeAlD
Glyburide—CYP2C19—digestive system—systemic scleroderma	0.000542	0.00906	CbGeAlD
Glyburide—ABCC1—tendon—systemic scleroderma	0.000528	0.00884	CbGeAlD
Glyburide—SLC15A2—lung—systemic scleroderma	0.000469	0.00785	CbGeAlD
Glyburide—ABCC1—lung—systemic scleroderma	0.000464	0.00776	CbGeAlD
Glyburide—CYP2C9—digestive system—systemic scleroderma	0.00042	0.00703	CbGeAlD
Glyburide—ABCG2—lung—systemic scleroderma	0.000384	0.00642	CbGeAlD
Glyburide—Alopecia—Lisinopril—systemic scleroderma	0.000345	0.00191	CcSEcCtD
Glyburide—Dyspepsia—Captopril—systemic scleroderma	0.000345	0.00191	CcSEcCtD
Glyburide—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00189	CcSEcCtD
Glyburide—Decreased appetite—Captopril—systemic scleroderma	0.000341	0.00189	CcSEcCtD
Glyburide—Malnutrition—Lisinopril—systemic scleroderma	0.00034	0.00188	CcSEcCtD
Glyburide—Erythema—Lisinopril—systemic scleroderma	0.00034	0.00188	CcSEcCtD
Glyburide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000338	0.00187	CcSEcCtD
Glyburide—Arthralgia—Leflunomide—systemic scleroderma	0.000337	0.00186	CcSEcCtD
Glyburide—Myalgia—Leflunomide—systemic scleroderma	0.000337	0.00186	CcSEcCtD
Glyburide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000335	0.00185	CcSEcCtD
Glyburide—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00183	CcSEcCtD
Glyburide—Vomiting—Pentoxifylline—systemic scleroderma	0.000329	0.00182	CcSEcCtD
Glyburide—Convulsion—Mycophenolic acid—systemic scleroderma	0.000327	0.00181	CcSEcCtD
Glyburide—Rash—Pentoxifylline—systemic scleroderma	0.000326	0.0018	CcSEcCtD
Glyburide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000326	0.0018	CcSEcCtD
Glyburide—Headache—Pentoxifylline—systemic scleroderma	0.000324	0.00179	CcSEcCtD
Glyburide—Feeling abnormal—Captopril—systemic scleroderma	0.000323	0.00179	CcSEcCtD
Glyburide—Myalgia—Mycophenolic acid—systemic scleroderma	0.000321	0.00178	CcSEcCtD
Glyburide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000321	0.00178	CcSEcCtD
Glyburide—Vision blurred—Lisinopril—systemic scleroderma	0.000321	0.00177	CcSEcCtD
Glyburide—Gastrointestinal pain—Captopril—systemic scleroderma	0.000321	0.00177	CcSEcCtD
Glyburide—Asthenia—Mometasone—systemic scleroderma	0.00032	0.00177	CcSEcCtD
Glyburide—CYP3A4—digestive system—systemic scleroderma	0.00032	0.00536	CbGeAlD
Glyburide—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00177	CcSEcCtD
Glyburide—Hypotension—Azathioprine—systemic scleroderma	0.00032	0.00177	CcSEcCtD
Glyburide—Tremor—Lisinopril—systemic scleroderma	0.000319	0.00176	CcSEcCtD
Glyburide—Nervous system disorder—Leflunomide—systemic scleroderma	0.000317	0.00175	CcSEcCtD
Glyburide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000316	0.00175	CcSEcCtD
Glyburide—Pruritus—Mometasone—systemic scleroderma	0.000316	0.00175	CcSEcCtD
Glyburide—Anaemia—Lisinopril—systemic scleroderma	0.000314	0.00174	CcSEcCtD
Glyburide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000312	0.00173	CcSEcCtD
Glyburide—Hepatic failure—Methotrexate—systemic scleroderma	0.000312	0.00173	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000312	0.00172	CcSEcCtD
Glyburide—Angioedema—Lisinopril—systemic scleroderma	0.000311	0.00172	CcSEcCtD
Glyburide—Confusional state—Mycophenolic acid—systemic scleroderma	0.000311	0.00172	CcSEcCtD
Glyburide—Abdominal pain—Captopril—systemic scleroderma	0.00031	0.00171	CcSEcCtD
Glyburide—Oedema—Mycophenolic acid—systemic scleroderma	0.000308	0.00171	CcSEcCtD
Glyburide—Anorexia—Leflunomide—systemic scleroderma	0.000308	0.0017	CcSEcCtD
Glyburide—Nausea—Pentoxifylline—systemic scleroderma	0.000307	0.0017	CcSEcCtD
Glyburide—Diarrhoea—Mometasone—systemic scleroderma	0.000305	0.00169	CcSEcCtD
Glyburide—Leukopenia—Lisinopril—systemic scleroderma	0.000304	0.00168	CcSEcCtD
Glyburide—Renal failure acute—Methotrexate—systemic scleroderma	0.000304	0.00168	CcSEcCtD
Glyburide—Shock—Mycophenolic acid—systemic scleroderma	0.000303	0.00168	CcSEcCtD
Glyburide—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00167	CcSEcCtD
Glyburide—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000302	0.00167	CcSEcCtD
Glyburide—Hypotension—Leflunomide—systemic scleroderma	0.000302	0.00167	CcSEcCtD
Glyburide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000302	0.00167	CcSEcCtD
Glyburide—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00165	CcSEcCtD
Glyburide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000298	0.00165	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—systemic scleroderma	0.000296	0.00164	CcSEcCtD
Glyburide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000295	0.00163	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000294	0.00163	CcSEcCtD
Glyburide—Anorexia—Mycophenolic acid—systemic scleroderma	0.000294	0.00163	CcSEcCtD
Glyburide—Abdominal distension—Prednisone—systemic scleroderma	0.000292	0.00161	CcSEcCtD
Glyburide—Paraesthesia—Leflunomide—systemic scleroderma	0.00029	0.0016	CcSEcCtD
Glyburide—Myalgia—Lisinopril—systemic scleroderma	0.00029	0.0016	CcSEcCtD
Glyburide—Arthralgia—Lisinopril—systemic scleroderma	0.00029	0.0016	CcSEcCtD
Glyburide—Dyspnoea—Leflunomide—systemic scleroderma	0.000288	0.00159	CcSEcCtD
Glyburide—Hypotension—Mycophenolic acid—systemic scleroderma	0.000288	0.00159	CcSEcCtD
Glyburide—Dyspepsia—Leflunomide—systemic scleroderma	0.000284	0.00157	CcSEcCtD
Glyburide—Pancreatitis—Prednisone—systemic scleroderma	0.000284	0.00157	CcSEcCtD
Glyburide—Vomiting—Mometasone—systemic scleroderma	0.000284	0.00157	CcSEcCtD
Glyburide—Sweating increased—Prednisone—systemic scleroderma	0.000282	0.00156	CcSEcCtD
Glyburide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000282	0.00156	CcSEcCtD
Glyburide—Rash—Mometasone—systemic scleroderma	0.000281	0.00156	CcSEcCtD
Glyburide—Asthenia—Captopril—systemic scleroderma	0.000281	0.00156	CcSEcCtD
Glyburide—Dermatitis—Mometasone—systemic scleroderma	0.000281	0.00156	CcSEcCtD
Glyburide—Decreased appetite—Leflunomide—systemic scleroderma	0.000281	0.00155	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000281	0.00155	CcSEcCtD
Glyburide—Confusional state—Lisinopril—systemic scleroderma	0.00028	0.00155	CcSEcCtD
Glyburide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00028	0.00155	CcSEcCtD
Glyburide—Headache—Mometasone—systemic scleroderma	0.00028	0.00155	CcSEcCtD
Glyburide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000279	0.00154	CcSEcCtD
Glyburide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000279	0.00154	CcSEcCtD
Glyburide—Oedema—Lisinopril—systemic scleroderma	0.000278	0.00154	CcSEcCtD
Glyburide—Pruritus—Captopril—systemic scleroderma	0.000277	0.00153	CcSEcCtD
Glyburide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000277	0.00153	CcSEcCtD
Glyburide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00152	CcSEcCtD
Glyburide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000275	0.00152	CcSEcCtD
Glyburide—Shock—Lisinopril—systemic scleroderma	0.000273	0.00151	CcSEcCtD
Glyburide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00151	CcSEcCtD
Glyburide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000272	0.0015	CcSEcCtD
Glyburide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000271	0.0015	CcSEcCtD
Glyburide—Abdominal pain—Azathioprine—systemic scleroderma	0.00027	0.0015	CcSEcCtD
Glyburide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000268	0.00148	CcSEcCtD
Glyburide—Diarrhoea—Captopril—systemic scleroderma	0.000268	0.00148	CcSEcCtD
Glyburide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000268	0.00148	CcSEcCtD
Glyburide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00148	CcSEcCtD
Glyburide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000266	0.00147	CcSEcCtD
Glyburide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000266	0.00147	CcSEcCtD
Glyburide—Nausea—Mometasone—systemic scleroderma	0.000265	0.00147	CcSEcCtD
Glyburide—Anorexia—Lisinopril—systemic scleroderma	0.000265	0.00146	CcSEcCtD
Glyburide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000264	0.00146	CcSEcCtD
Glyburide—Hypotension—Lisinopril—systemic scleroderma	0.000259	0.00144	CcSEcCtD
Glyburide—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00143	CcSEcCtD
Glyburide—Urticaria—Leflunomide—systemic scleroderma	0.000257	0.00142	CcSEcCtD
Glyburide—Abdominal pain—Leflunomide—systemic scleroderma	0.000255	0.00141	CcSEcCtD
Glyburide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000254	0.00141	CcSEcCtD
Glyburide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.0014	CcSEcCtD
Glyburide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.0014	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000253	0.0014	CcSEcCtD
Glyburide—Hypersensitivity—Azathioprine—systemic scleroderma	0.000252	0.00139	CcSEcCtD
Glyburide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000252	0.00139	CcSEcCtD
Glyburide—Paraesthesia—Lisinopril—systemic scleroderma	0.000249	0.00138	CcSEcCtD
Glyburide—Vomiting—Captopril—systemic scleroderma	0.000249	0.00138	CcSEcCtD
Glyburide—Dyspnoea—Lisinopril—systemic scleroderma	0.000247	0.00137	CcSEcCtD
Glyburide—Rash—Captopril—systemic scleroderma	0.000247	0.00137	CcSEcCtD
Glyburide—Dermatitis—Captopril—systemic scleroderma	0.000247	0.00137	CcSEcCtD
Glyburide—Headache—Captopril—systemic scleroderma	0.000246	0.00136	CcSEcCtD
Glyburide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00136	CcSEcCtD
Glyburide—Dyspepsia—Lisinopril—systemic scleroderma	0.000244	0.00135	CcSEcCtD
Glyburide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000244	0.00135	CcSEcCtD
Glyburide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00135	CcSEcCtD
Glyburide—Decreased appetite—Lisinopril—systemic scleroderma	0.000241	0.00134	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—systemic scleroderma	0.00024	0.00133	CcSEcCtD
Glyburide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00024	0.00133	CcSEcCtD
Glyburide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00132	CcSEcCtD
Glyburide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00132	CcSEcCtD
Glyburide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000238	0.00132	CcSEcCtD
Glyburide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000238	0.00132	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—systemic scleroderma	0.000238	0.00131	CcSEcCtD
Glyburide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000235	0.0013	CcSEcCtD
Glyburide—Diarrhoea—Azathioprine—systemic scleroderma	0.000234	0.00129	CcSEcCtD
Glyburide—Nausea—Captopril—systemic scleroderma	0.000233	0.00129	CcSEcCtD
Glyburide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00128	CcSEcCtD
Glyburide—Asthenia—Leflunomide—systemic scleroderma	0.000232	0.00128	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—systemic scleroderma	0.00023	0.00127	CcSEcCtD
Glyburide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000229	0.00127	CcSEcCtD
Glyburide—Pruritus—Leflunomide—systemic scleroderma	0.000229	0.00126	CcSEcCtD
Glyburide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00126	CcSEcCtD
Glyburide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000227	0.00126	CcSEcCtD
Glyburide—ABCB1—digestive system—systemic scleroderma	0.000227	0.00379	CbGeAlD
Glyburide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00123	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000221	0.00122	CcSEcCtD
Glyburide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000221	0.00122	CcSEcCtD
Glyburide—Diarrhoea—Leflunomide—systemic scleroderma	0.000221	0.00122	CcSEcCtD
Glyburide—Urticaria—Lisinopril—systemic scleroderma	0.000221	0.00122	CcSEcCtD
Glyburide—Abdominal pain—Lisinopril—systemic scleroderma	0.000219	0.00121	CcSEcCtD
Glyburide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00121	CcSEcCtD
Glyburide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000218	0.00121	CcSEcCtD
Glyburide—Vomiting—Azathioprine—systemic scleroderma	0.000218	0.0012	CcSEcCtD
Glyburide—Eye disorder—Prednisone—systemic scleroderma	0.000217	0.0012	CcSEcCtD
Glyburide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000217	0.0012	CcSEcCtD
Glyburide—Rash—Azathioprine—systemic scleroderma	0.000216	0.00119	CcSEcCtD
Glyburide—Dermatitis—Azathioprine—systemic scleroderma	0.000215	0.00119	CcSEcCtD
Glyburide—Headache—Azathioprine—systemic scleroderma	0.000214	0.00119	CcSEcCtD
Glyburide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00118	CcSEcCtD
Glyburide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000211	0.00117	CcSEcCtD
Glyburide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000211	0.00117	CcSEcCtD
Glyburide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00116	CcSEcCtD
Glyburide—Vomiting—Leflunomide—systemic scleroderma	0.000205	0.00114	CcSEcCtD
Glyburide—Alopecia—Prednisone—systemic scleroderma	0.000205	0.00113	CcSEcCtD
Glyburide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000205	0.00113	CcSEcCtD
Glyburide—Rash—Leflunomide—systemic scleroderma	0.000204	0.00113	CcSEcCtD
Glyburide—Dermatitis—Leflunomide—systemic scleroderma	0.000204	0.00113	CcSEcCtD
Glyburide—Nausea—Azathioprine—systemic scleroderma	0.000203	0.00112	CcSEcCtD
Glyburide—Headache—Leflunomide—systemic scleroderma	0.000202	0.00112	CcSEcCtD
Glyburide—Erythema—Prednisone—systemic scleroderma	0.000202	0.00112	CcSEcCtD
Glyburide—Malnutrition—Prednisone—systemic scleroderma	0.000202	0.00112	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000202	0.00112	CcSEcCtD
Glyburide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0002	0.00111	CcSEcCtD
Glyburide—Asthenia—Lisinopril—systemic scleroderma	0.000199	0.0011	CcSEcCtD
Glyburide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000199	0.0011	CcSEcCtD
Glyburide—Pruritus—Lisinopril—systemic scleroderma	0.000196	0.00109	CcSEcCtD
Glyburide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000196	0.00108	CcSEcCtD
Glyburide—Rash—Mycophenolic acid—systemic scleroderma	0.000194	0.00108	CcSEcCtD
Glyburide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000194	0.00107	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—systemic scleroderma	0.000194	0.00107	CcSEcCtD
Glyburide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00107	CcSEcCtD
Glyburide—Headache—Mycophenolic acid—systemic scleroderma	0.000193	0.00107	CcSEcCtD
Glyburide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00106	CcSEcCtD
Glyburide—Nausea—Leflunomide—systemic scleroderma	0.000192	0.00106	CcSEcCtD
Glyburide—Vision blurred—Prednisone—systemic scleroderma	0.00019	0.00105	CcSEcCtD
Glyburide—Diarrhoea—Lisinopril—systemic scleroderma	0.00019	0.00105	CcSEcCtD
Glyburide—ABCB1—lung—systemic scleroderma	0.000189	0.00317	CbGeAlD
Glyburide—Visual impairment—Methotrexate—systemic scleroderma	0.000187	0.00103	CcSEcCtD
Glyburide—Anaemia—Prednisone—systemic scleroderma	0.000187	0.00103	CcSEcCtD
Glyburide—Angioedema—Prednisone—systemic scleroderma	0.000185	0.00102	CcSEcCtD
Glyburide—Nausea—Mycophenolic acid—systemic scleroderma	0.000183	0.00101	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—systemic scleroderma	0.000181	0.001	CcSEcCtD
Glyburide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000991	CcSEcCtD
Glyburide—Vomiting—Lisinopril—systemic scleroderma	0.000176	0.000976	CcSEcCtD
Glyburide—Rash—Lisinopril—systemic scleroderma	0.000175	0.000968	CcSEcCtD
Glyburide—Convulsion—Prednisone—systemic scleroderma	0.000175	0.000968	CcSEcCtD
Glyburide—Dermatitis—Lisinopril—systemic scleroderma	0.000175	0.000967	CcSEcCtD
Glyburide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000965	CcSEcCtD
Glyburide—Headache—Lisinopril—systemic scleroderma	0.000174	0.000962	CcSEcCtD
Glyburide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000952	CcSEcCtD
Glyburide—Myalgia—Prednisone—systemic scleroderma	0.000172	0.000951	CcSEcCtD
Glyburide—Arthralgia—Prednisone—systemic scleroderma	0.000172	0.000951	CcSEcCtD
Glyburide—Alopecia—Methotrexate—systemic scleroderma	0.000171	0.000948	CcSEcCtD
Glyburide—Erythema—Methotrexate—systemic scleroderma	0.000169	0.000934	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—systemic scleroderma	0.000169	0.000934	CcSEcCtD
Glyburide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000921	CcSEcCtD
Glyburide—Nausea—Lisinopril—systemic scleroderma	0.000165	0.000912	CcSEcCtD
Glyburide—Oedema—Prednisone—systemic scleroderma	0.000165	0.000912	CcSEcCtD
Glyburide—Shock—Prednisone—systemic scleroderma	0.000162	0.000897	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—systemic scleroderma	0.000162	0.000894	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000159	0.000882	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—systemic scleroderma	0.000159	0.00088	CcSEcCtD
Glyburide—Anorexia—Prednisone—systemic scleroderma	0.000157	0.000869	CcSEcCtD
Glyburide—Anaemia—Methotrexate—systemic scleroderma	0.000156	0.000863	CcSEcCtD
Glyburide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000856	CcSEcCtD
Glyburide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000848	CcSEcCtD
Glyburide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000848	CcSEcCtD
Glyburide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000843	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—systemic scleroderma	0.000151	0.000836	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00015	0.000831	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—systemic scleroderma	0.000148	0.000819	CcSEcCtD
Glyburide—Convulsion—Methotrexate—systemic scleroderma	0.000146	0.000809	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—systemic scleroderma	0.000145	0.000803	CcSEcCtD
Glyburide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000799	CcSEcCtD
Glyburide—Myalgia—Methotrexate—systemic scleroderma	0.000144	0.000795	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—systemic scleroderma	0.000144	0.000795	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—systemic scleroderma	0.000143	0.000793	CcSEcCtD
Glyburide—Confusional state—Methotrexate—systemic scleroderma	0.000139	0.000769	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—systemic scleroderma	0.000136	0.000752	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—systemic scleroderma	0.000135	0.000748	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000135	0.000746	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000135	0.000746	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000133	0.000737	CcSEcCtD
Glyburide—Anorexia—Methotrexate—systemic scleroderma	0.000131	0.000727	CcSEcCtD
Glyburide—Urticaria—Prednisone—systemic scleroderma	0.000131	0.000725	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—systemic scleroderma	0.00013	0.000721	CcSEcCtD
Glyburide—Hypotension—Methotrexate—systemic scleroderma	0.000129	0.000712	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000126	0.000694	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—systemic scleroderma	0.000124	0.000684	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—systemic scleroderma	0.000123	0.00068	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—systemic scleroderma	0.000121	0.000672	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—systemic scleroderma	0.000121	0.000671	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—systemic scleroderma	0.00012	0.000663	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000119	0.000658	CcSEcCtD
Glyburide—Asthenia—Prednisone—systemic scleroderma	0.000118	0.000654	CcSEcCtD
Glyburide—Pruritus—Prednisone—systemic scleroderma	0.000117	0.000645	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000114	0.000628	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—systemic scleroderma	0.000113	0.000624	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000113	0.000623	CcSEcCtD
Glyburide—Urticaria—Methotrexate—systemic scleroderma	0.000109	0.000606	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—systemic scleroderma	0.000109	0.000603	CcSEcCtD
Glyburide—Vomiting—Prednisone—systemic scleroderma	0.000105	0.00058	CcSEcCtD
Glyburide—Rash—Prednisone—systemic scleroderma	0.000104	0.000575	CcSEcCtD
Glyburide—Dermatitis—Prednisone—systemic scleroderma	0.000104	0.000575	CcSEcCtD
Glyburide—Headache—Prednisone—systemic scleroderma	0.000103	0.000571	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000102	0.000562	CcSEcCtD
Glyburide—Asthenia—Methotrexate—systemic scleroderma	9.89e-05	0.000547	CcSEcCtD
Glyburide—Nausea—Prednisone—systemic scleroderma	9.79e-05	0.000542	CcSEcCtD
Glyburide—Pruritus—Methotrexate—systemic scleroderma	9.75e-05	0.000539	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—systemic scleroderma	9.43e-05	0.000522	CcSEcCtD
Glyburide—Vomiting—Methotrexate—systemic scleroderma	8.76e-05	0.000485	CcSEcCtD
Glyburide—Rash—Methotrexate—systemic scleroderma	8.69e-05	0.000481	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—systemic scleroderma	8.68e-05	0.00048	CcSEcCtD
Glyburide—Headache—Methotrexate—systemic scleroderma	8.63e-05	0.000478	CcSEcCtD
Glyburide—Nausea—Methotrexate—systemic scleroderma	8.18e-05	0.000453	CcSEcCtD
